Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
23.96
-1.19 (-4.73%)
At close: Apr 28, 2026, 4:00 PM EDT
23.50
-0.46 (-1.92%)
After-hours: Apr 28, 2026, 5:19 PM EDT
Crescent Biopharma Employees
Crescent Biopharma had 44 employees as of December 31, 2025. The number of employees increased by 38 or 633.33% compared to the previous year.
Employees
44
Change (1Y)
38
Growth (1Y)
633.33%
Revenue / Employee
$246,455
Profits / Employee
-$3,498,682
Market Cap
796.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 44 | 38 | 633.33% |
| Dec 31, 2024 | 6 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MannKind | 592 |
| MeiraGTx Holdings | 403 |
| Kura Oncology | 260 |
| ARS Pharmaceuticals | 163 |
| Allogene Therapeutics | 152 |
| Cullinan Therapeutics | 109 |
| Theravance Biopharma | 90 |
| Alto Neuroscience | 68 |
CBIO News
- 4 days ago - Crescent Biopharma Announces Grants of Inducement Awards - GlobeNewsWire
- 6 weeks ago - Crescent Biopharma Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 2 months ago - Crescent Biopharma Transcript: TD Cowen 46th Annual Health Care Conference - Transcripts
- 2 months ago - Crescent Biopharma Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights - GlobeNewsWire
- 2 months ago - Crescent Biopharma to Present at March Investor Conferences - GlobeNewsWire
- 2 months ago - Crescent Biopharma Announces First Patient Dosed in ASCEND Phase 1/2 Clinical Trial of CR-001 for the Treatment of Advanced Solid Tumors - GlobeNewsWire
- 2 months ago - Crescent Biopharma Transcript: Guggenheim Securities Emerging Outlook: Biotech Summit 2026 - Transcripts
- 2 months ago - Crescent Biopharma to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 - GlobeNewsWire